Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria Transcript
Source: SeekingAlpha
2026-01-08 11:44:52 ET
Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria January 8, 2026 8:00 AM EST...
Read the full article on Seeking Alpha
For further details see:
Jasper Therapeutics, Inc. (JSPR) Discusses Updated Data from BEACON and Open-Label Extension Studies in Chronic Urticaria Transcript
Jasper Therapeutics Inc. Warrant
NASDAQ: JSPRW
JSPRW Trading
-0.43% G/L:
$0.0229 Last:
259 Volume:
$0.0209 Open:
JSPRW Latest News
JSPRW Stock Data
$31,744,475
21,939,487
N/A
33
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
